Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Not on Peppol Peppol
Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.
Financials
Financial year 2025
Dr C. Ridremont, pédiatre from Ukkel, company number BE1017385785, closed financial year 2025 with a result of € 158,010 after tax. For that financial year Dr C. Ridremont, pédiatre recorded a gross margin of € 216,790 and equity of € 159,010. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 24, 2026.
€ 159,010
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 158,010
Profit after tax over the fiscal year.
€ 25,025
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 158,010.
People and assets in 2025
€ 19,506
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 274
Loans from banks and other lenders, long and short.
€ 717
Supplier invoices still open on the last day of the fiscal year.
€ 14,494
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
What happened to Dr C. Ridremont, pédiatre?
What happened at Dr C. Ridremont, pédiatre in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 158,010. Source: NBB ↗
- New establishment in Ukkel. KBO
- Start of the company according to the CBE. KBO
In short
Paid € 54,494 in corporate taxes since 2025.
A new publication or filing at Dr C. Ridremont, pédiatre? We notify you, reason included.
Follow Dr C. Ridremont, pédiatreDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind Dr C. Ridremont, pédiatre are Céline RIDREMONT and David BOUCHEZ. The same people are also behind SYNAPTICORE. Céline RIDREMONT is also behind Céline Ridremont,pédiatre,néonatologue. David BOUCHEZ is also behind Fair Genomics.
Directors
According to the 2025 annual accounts
Establishments
Establishment units
Physical locations of this company
Hoeflaan 6
1180 Ukkel
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 1017.385.785
- VAT number
- BE 1017.385.785
- Registered office
- Hoeflaan 6, 1180 Ukkel
- Names & denominations
- Dr C. Ridremont, pédiatre
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 13 December 2024
- Peppol
- Not registered
- Contact
- [email protected]